LGND

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Ligand Pharmaceuticals (LGND) Earnings Date & Reports

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

LGND is expected to report earnings to fall 3.94% to $1.22 per share on April 30

Ligand Pharmaceuticals LGND Stock Earnings Reports

Q1'25

Est.

$1.22

Q4'24

Beat

by $0.09

Q3'24

Beat

by $0.50

Q2'24

Beat

by $0.34

Q1'24

Beat

by $0.36

The last earnings report on February 27 showed earnings per share of $1.27, beating the estimate of $1.18. With 10.90K shares outstanding, the current market capitalization sits at 2.07B.

View a ticker or compare two or three

Compare

LGND

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LGND
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for LGND (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

555 Heritage Drive

Phone

+1 858 550-7500

Employees

Web

https://www.ligand.com